Literature DB >> 10698520

Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo.

V A Krutovskikh1, S M Troyanovsky, C Piccoli, H Tsuda, M Asamoto, H Yamasaki.   

Abstract

There is a large body of evidence suggesting the connexin gap junction proteins appear to act as tumor suppressors, and their tumor inhibitory effect is usually attributed to their main function of cell coupling through gap junctions. However, some cancer cells (e.g. the rat bladder carcinoma BC31 cell line) are cell-cell communication proficient. Using specific site-directed mutagenesis in the third membrane-spanning (3M) domain of connexin43 (Cx43), we abolished the intrinsic gap junction intercellular communication (GJIC) in BC31 cells either by closing the gap junctional channels or by disruption of the transport of connexin complexes to the lateral membrane. Clones of BC31 cells transfected with a dominant negative Cx43 mutant giving rise to gap junctional channels, permeable only for a small tracer (neurobiotin), displayed accelerated growth rate in vivo, showing the critical role of selective gap junctional permeability in the regulation of cell growth in vivo. The use of other dominant-negative mutants of Cx43 also suggested that the effect of impaired communication on the tumorigenicity of cancer cells depends on the subcellular location of connexin. Inhibition of intrinsic GJIC in BC31 cells by sequestering of Cx protein inside the cytoplasm, due to expression of dominant-negative transport-deficient Cx43 mutants, did not significantly enhance the growth of transfectants in nude mice, but occasionally slightly retarded it. In contrast, augmentation of GJIC in BC31 cells by forced expression of wild-type Cx43, or a communication-silent mutant, fully suppressed tumorigenicity of these cells. Overall, these results show that cell coupling is a strong, but not the sole, mechanism by which Cx suppresses growth of tumorigenic cells in vivo; a GJIC-independent activity of Cx proteins should be considered as another strong tumor-suppressive factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698520     DOI: 10.1038/sj.onc.1203340

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

Review 1.  Regulation of gap junctions by tyrosine protein kinases.

Authors:  Bonnie J Warn-Cramer; Alan F Lau
Journal:  Biochim Biophys Acta       Date:  2004-03-23

Review 2.  Gap junction- and hemichannel-independent actions of connexins.

Authors:  Jean X Jiang; Sumin Gu
Journal:  Biochim Biophys Acta       Date:  2004-10-22

3.  Au-Fe3O4 dumbbell nanoparticles as dual-functional probes.

Authors:  Chenjie Xu; Jin Xie; Don Ho; Chao Wang; Nathan Kohler; Edward G Walsh; Jeffrey R Morgan; Y Eugene Chin; Shouheng Sun
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 4.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

5.  Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer.

Authors:  Luiza Kanczuga-Koda; Stanislaw Sulkowski; Mariusz Koda; Elzbieta Skrzydlewska; Mariola Sulkowska
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells.

Authors:  Ralph Brehm; Christina Rüttinger; Petra Fischer; Isabella Gashaw; Elke Winterhager; Sabine Kliesch; Rainer M Bohle; Klaus Steger; Martin Bergmann
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

7.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

8.  Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes.

Authors:  Bo Tang; Zhi-Hong Peng; Pei-Wu Yu; Ge Yu; Feng Qian
Journal:  Med Oncol       Date:  2010-04-06       Impact factor: 3.064

9.  The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells.

Authors:  Coralie Lamiche; Jonathan Clarhaut; Pierre-Olivier Strale; Sophie Crespin; Nathalie Pedretti; François-Xavier Bernard; Christian C Naus; Vincent C Chen; Leonard J Foster; Norah Defamie; Marc Mesnil; Françoise Debiais; Laurent Cronier
Journal:  Clin Exp Metastasis       Date:  2011-11-12       Impact factor: 5.150

Review 10.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.